Sarepta Therapeutics Inc (NASDAQ:SRPT) shares saw strong trading volume on Friday after Cantor Fitzgerald raised their price target on the stock from $175.00 to $211.00. Cantor Fitzgerald currently has an overweight rating on the stock. 10,790,598 shares changed hands during mid-day trading, an increase of 673% from the previous session’s volume of 1,395,266 shares.The stock last traded at $132.05 and had previously closed at $100.47
A number of other equities analysts have also issued reports on the company. Janney Montgomery Scott upped their target price on Sarepta Therapeutics from $160.00 to $175.00 and gave the company a “buy” rating in a research report on Friday. Leerink Swann upped their target price on Sarepta Therapeutics from $186.00 to $216.00 and gave the company an “outperform” rating in a research report on Friday. Guggenheim assumed coverage on Sarepta Therapeutics in a research report on Friday, November 1st. They issued a “buy” rating and a $183.00 target price on the stock.
——-_____________________\\
So this is the space to be in —DMD..
Can’t wait for Monday..$$$$
ATL1102 Blockbuster drug in 2020 and a Coy maker., page-2
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $69.41M | |||
| Open | High | Low | Value | Volume |
| 7.7¢ | 7.9¢ | 7.6¢ | $148.9K | 1.895M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 48919 | 7.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.9¢ | 70000 | 1 |
View Market Depth
| Last trade - 15.59pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
7.8¢ |
Change
0.000 ( 2.63 %) |
||||
| Open | High | Low | Volume | ||
| 7.7¢ | 7.9¢ | 7.7¢ | 43057 | ||
| Last updated 13.04pm 03/05/2024 ? | |||||
| PER (ASX) Chart |